Timothy A Graubert

7PUBLICATIONS
79CO-AUTHORS
Regenerative medicine (incl. stem cells)Innate immunityMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 06, 2026
U2af1S34F and U2af1Q157R myeloid neoplasm-associated hotspot mutations induce distinct hematopoietic phenotypes in mice.

|Apr 09, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity.

Jooho Chung, Mounica Vallurupalli, Sarah Noel

|Apr 09, 2026
Nonsense-Mediated RNA Decay Is a Targetable Vulnerability in Splicing Factor Mutant Myeloid Neoplasms by Enhancing R-Loop Accumulation and DNA Damage.

Claudia Cabrera Pastrana, Sridhar Nonavinkere Srivatsan, Michael O Alberti

|Nov 24, 2025
Sensitivity to ATR-CHK1 pathway inhibition in AML/MDS is enhanced by SRSF2 mutations and reduced by RUNX1 loss.

Samuli Eldfors, Sumit Rai, Vineet Sharma

|Nov 15, 2023
R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription-Replication Conflicts.

Zhiyan Silvia Liu, Sayantani Sinha, Maxwell Bannister

|Dec 13, 2016
Splicing factor gene mutations in hematologic malignancies.

Borja Saez, Matthew J Walter, Timothy A Graubert

Pageof 2

Frequent Collaborators

6 joint publications

Matthew Walter

3 joint publications

Claudia Cabrera Pastrana

2 joint publications

Sridhar Nonavinkere Srivatsan

2 joint publications

Michael O Alberti